The Relevance of Curative‐Intent Metastasectomy in Colorectal Cancer Patients: Real‐World Insights From a Certified Comprehensive Cancer Center in Germany
International Journal of Cancer · 15.10.2026 · 159 (8) · 2025-2035
DOI: 10.1002/ijc.70540 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 09.05.2026. Verfasst von Julian W Holch und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Metastasectomy. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Long‐term survival in metastatic colorectal cancer (mCRC) can be achieved by curative‐intent metastasectomy. Patients ineligible for upfront (primary) metastasectomy (PM) may become candidates for secondary metastasectomy (SM) following response to primary chemotherapy (PCT), still with curative intent. Most studies focus either on resectable or unresectable mCRC, limiting insights into differential subgroup benefits. Here, real‐world data offer a comprehensive evaluation of PM, SM, and PCT. We analyzed real‐world data from mCRC patients treated at the certified Comprehensive Cancer Center of the LMU Hospital (CCC Munich LMU ) from 2007 to 2021, following ESMO's guidance for real‐world evidence (GROW). Overall survival (OS) data were matched with the Bavarian Cancer Registry. OS was assessed using Kaplan–Meier estimates and Cox regression analysis, adjusting for prognostic factors, including primary tumor sidedness and number of metastatic sites. Of 840 evaluable patients, 166 (20%) underwent PM, 520 (62%) received PCT, and 109 (13%) became eligible for SM after response to systemic treatment. OS was significantly longer for PM versus PCT (82.3 vs. 41.6 months, HR = 0.47, p < 0.0001). Multivariate analysis confirmed PM benefit across all subgroups, including high‐risk patients (e.g., right‐sided and multisite mCRC). OS was comparable between PM and SM (82.3 vs. 80.9 months), whereas patients ineligible for local treatments had the worst OS (25 months). Both PM and SM were associated with excellent OS, also for patients with high‐risk mCRC. Our findings underscore the importance of initial evaluation and continuous reassessment of resectability throughout the course of treatment against mCRC, as implemented at the CCC Munich LMU .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
- Comprehensive Cancer Center (CCC MunichLMU), LMU University Hospital Munich, Munich, Germany.
- German Cancer Consortium (DKTK), Partner Site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Bavarian Cancer Research Center (BZKF), Munich, Germany.
- Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
- National Center for Radiation Research in Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.
ORCID-Profile: Julian W Holch, Jo-Ann Eisenburger
Zitieren
APA
Holch, J. W., Eisenburger, J. A., Weber, A., Kammermeier-Wehlau, I., Wiberg, Y., Allmendinger, F., Heinrich, K., Weiss, L., Westphalen, C. B., Krenmayr, V., Dorman, K., Zhang, D., Fey, T., Berger-Thürmel, K., Wirth, U., Kühn, F., von Bergwelt-Baildon, M., Werner, J., & Heinemann, V. (2026). The Relevance of Curative‐Intent Metastasectomy in Colorectal Cancer Patients: Real‐World Insights From a Certified Comprehensive Cancer Center in Germany. International Journal of Cancer, 159(8), 2025-2035. https://doi.org/10.1002/ijc.70540
Vancouver
Holch JW, Eisenburger JA, Weber A, Kammermeier-Wehlau I, Wiberg Y, Allmendinger F, et al. The Relevance of Curative‐Intent Metastasectomy in Colorectal Cancer Patients: Real‐World Insights From a Certified Comprehensive Cancer Center in Germany. International Journal of Cancer. 2026;159(8):2025-2035. doi:10.1002/ijc.70540
BibTeX
@article{Holch2026,
author = {Holch, Julian W and Eisenburger, Jo-Ann and Weber, Antony and Kammermeier-Wehlau, Iris and Wiberg, Yannick and Allmendinger, Fabian and Heinrich, Kathrin and Weiss, Lena and Westphalen, C Benedikt and Krenmayr, Victoria and Dorman, Klara and Zhang, Danmei and Fey, Theres and Berger-Thürmel, Karin and Wirth, Ulrich and Kühn, Florian and von Bergwelt-Baildon, Michael and Werner, Jens and Heinemann, Volker},
title = {The Relevance of Curative‐Intent Metastasectomy in Colorectal Cancer Patients: Real‐World Insights From a Certified Comprehensive Cancer Center in Germany},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {8},
pages = {2025--2035},
doi = {10.1002/ijc.70540}
}
EUVIMED